TMCnet News
Research and Markets: Fibromyalgia - Pipeline Review, H1 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/v8qbsn/fibromyalgia) has announced the addition of the "Fibromyalgia - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Fibromyalgia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibromyalgia and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that allthe profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/v8qbsn/fibromyalgia
|